McDonald, A., Burke, K., Gao, F., Kuan, S., Theisen, M., Blakemore, S. J., … Tirrell, S. (2012). PHARMACODYNAMIC ASSAYS DEMONSTRATE NAE PATHWAY INHIBITION FOLLOWING ADMINISTRATION OF MLN4924 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. In HAEMATOLOGICA (Vol. 97, pp. 33–33). FERRATA STORTI FOUNDATION.

McDonald, A., K. Burke, F. Gao, S. Kuan, M. Theisen, S. J. Blakemore, A. Berger, et al. “PHARMACODYNAMIC ASSAYS DEMONSTRATE NAE PATHWAY INHIBITION FOLLOWING ADMINISTRATION OF MLN4924 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.” In HAEMATOLOGICA, 97:33–33. FERRATA STORTI FOUNDATION, 2012.

McDonald A, Burke K, Gao F, Kuan S, Theisen M, Blakemore SJ, et al. PHARMACODYNAMIC ASSAYS DEMONSTRATE NAE PATHWAY INHIBITION FOLLOWING ADMINISTRATION OF MLN4924 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2012. p. 33–33.

McDonald, A., et al. “PHARMACODYNAMIC ASSAYS DEMONSTRATE NAE PATHWAY INHIBITION FOLLOWING ADMINISTRATION OF MLN4924 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.” HAEMATOLOGICA, vol. 97, FERRATA STORTI FOUNDATION, 2012, pp. 33–33.

McDonald A, Burke K, Gao F, Kuan S, Theisen M, Blakemore SJ, Berger A, Fleming M, Dezube B, Erba H, Medeiros B, DeAngelo D, Swords R, Tirrell S. PHARMACODYNAMIC ASSAYS DEMONSTRATE NAE PATHWAY INHIBITION FOLLOWING ADMINISTRATION OF MLN4924 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2012. p. 33–33.